Who
Liam Kelly
Director
Company insider
Files Form 4 as: Director, Enovis; Chairman, President & CEO, Teleflex.
In numbers
- Trades disclosed
- 124
- Buys
- 2
- Sells
- 5
- Bought
- $322K
- Sold
- $17.4M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 25 Jun 2012
- Last trade
- 19 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 May 2026filed 21 May 2026 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —9,346 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —9,346 at $0.00 | filing |
| 5 Aug 2025filed 7 Aug 2025 | TFX TeleflexMedical Devices | SEC FORM 4 Bought | $173K1,500 at $115.07 | filing |
| 21 May 2025filed 23 May 2025 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —6,598 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2025 | TFX Teleflexoption or derivative · Medical Devices | SEC FORM 4 Code A | —71,983 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2025 | TFX TeleflexMedical Devices | SEC FORM 4 Code A | —10,195 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | TFX TeleflexMedical Devices | SEC FORM 4 Code F | $276K2,081 at $132.75 | filing |
| 24 Feb 2025filed 26 Feb 2025 | TFX TeleflexMedical Devices | SEC FORM 4 Code A | —1,317 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | TFX Teleflexoption or derivative · Medical Devices | SEC FORM 4 Code M | —29,084 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | TFX Teleflexoption or derivative · Medical Devices | SEC FORM 4 Code M | —7,380 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | TFX TeleflexMedical Devices | SEC FORM 4 Code M | $3.5M29,084 at $121.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | TFX TeleflexMedical Devices | SEC FORM 4 Code M | $908K7,380 at $123.04 | filing |
| 19 Feb 2025filed 21 Feb 2025 | TFX TeleflexMedical Devices | SEC FORM 4 Code F | $5.0M29,220 at $171.29 | filing |
| 20 May 2024filed 22 May 2024 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —4,338 at $0.00 | filing |
| 2 Mar 2024filed 5 Mar 2024 | TFX TeleflexMedical Devices | SEC FORM 4 Code F | $410K1,840 at $223.00 | filing |
| 27 Feb 2024filed 20 Jun 2024 | TFX Teleflexoption or derivative · Medical Devices | SEC FORM 4 Code A | —48,094 at $0.00 | filing |
| 27 Feb 2024filed 20 Jun 2024 | TFX TeleflexMedical Devices | SEC FORM 4 Code A | —6,858 at $0.00 | filing |
| 27 Feb 2024filed 28 Feb 2024 | TFX Teleflexoption or derivative · Medical Devices | SEC FORM 4 Code A | —48,094 at $0.00 | filing |
| 27 Feb 2024filed 28 Feb 2024 | TFX TeleflexMedical Devices | SEC FORM 4 Code A | —6,787 at $0.00 | filing |
| 19 Feb 2024filed 21 Feb 2024 | TFX TeleflexMedical Devices | SEC FORM 4 Code A | —1,856 at $0.00 | filing |
News
Nyxoah Appoints Liam Kelly as Chief Executive Officermanilatimes.net · 28 Sep 2026Contrasting Teleflex (NYSE:TFX) & Trinity Biotech (NASDAQ:TRIB)TFX · tickerreport.com · 16 Oct 2026Enovis (NYSE:ENOV) and electroCore (NASDAQ:ECOR) Head to Head SurveyENOV · themarketsdaily.com · 11 Oct 2026Enovis (NYSE:ENOV) versus electroCore (NASDAQ:ECOR) Financial ContrastENOV · tickerreport.com · 9 Oct 2026Enovis (NYSE:ENOV) Sets New 12-Month Low – Here's WhyENOV · dailypolitical.com · 8 Oct 2026
1 headline in the last 90 days name Liam Kelly; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.